Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 41Non-Muscle Invasive Bladder Neoplasms 25Colorectal Neoplasms 20Anus Neoplasms 17Carcinoma, Transitional Cell 15Neoplasm Metastasis 12Carcinoma, Hepatocellular 10Appendiceal Neoplasms 10Stomach Neoplasms 9Peritoneal Neoplasms 9Pancreatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Neoplasms 6Lung Neoplasms 6Colonic Neoplasms 6Rectal Neoplasms 5Liver Neoplasms 5Sarcoma 4Anal Canal Carcinoma 4Urologic Neoplasms 3Urologic Diseases 3Urinary Bladder Diseases 3Pseudomyxoma Peritonei 3Mesothelioma, Malignant 3Gastrointestinal Neoplasms 3Carcinoma in Situ 3Carcinoma 3Breast Neoplasms 3Urogenital Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2

Interventions

Gemcitabine 25Cisplatin 18Carboplatin 10Paclitaxel 9Specimen Handling 6Nivolumab 6Doxorubicin 6Docetaxel 6pembrolizumab 5Magnetic Resonance Spectroscopy 5cabozantinib 4avelumab 4Vinblastine 4Radiotherapy 4Methotrexate 4Fluorouracil 4enfortumab vedotin 3atezolizumab 3aflibercept 3Trastuzumab 3Sunitinib 3Ramucirumab 3Platinum 3Ipilimumab 3Immunoglobulin G 3Disulfides 3CTLA-4 Antigen 3Biopsy 31,2-diaminocyclohexaneplatinum II citrate 3vinflunine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Urethral Neoplasms × Mitomycin × Clear all
NCT03617913 2023-01-06

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

Mayo Clinic

Phase 2 Completed
2 enrolled 8 charts
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡